Monday, July 8, at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis (EAA), is an immune-mediated interstitial lung disease triggered by inhaled antigens such as molds, bird feathers, and agricultural dusts. Often linked to working conditions, HP is a disease of many faces, from inflammatory self-limiting disease to relapsing or progressive inflammatory disease and chronic fibrotic disease. As there does not exist a single, universal diagnostic criterion, HP is diagnosed by a combination of findings established through clinical history, including imaging, histopathology, pulmonary function testing, bronchoscopy, and serology. With the rise of automated immunoassays capable of quantitatively measuring specific IgG to common HP antigens, an expanded diagnostic can be used to detect the potential triggering antigen.
This webinar delves into the pathophysiology of HP, highlights the diagnostic criteria according to the current guidelines, and emphasizes the utility of specific IgG determination and the importance of cutoff values in HP.
Key learning objectives
- Describe the pathophysiology of hypersensitivity pneumonitis
- Explain the diagnostic criteria used to establish HP
- Discuss the value of serology in HP
Accreditation statement
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Presenters
Dora Wells
Editorial Team
SelectScience
Dr. Johannes Grosch
Clinical Expert
Siemens Healthineers
Dr. Johannes Grosch is a clinical expert at Siemens Healthineers and a member of the global product management team for IMMULITE® systems. His academic journey began with a degree in nutritional sciences from the University of Vienna, followed by advanced studies in biochemistry at the Technical University Braunschweig.
In 2016, Dr. Grosch joined the Center of Allergy and Environment at the Technical University of Munich and Helmholtz Zentrum Munich, where he focused on the molecular aspects of Hymenoptera venom allergies. His research delved into venom composition, allergen characterization, and the monitoring of allergy immunotherapy.
Transitioning from academia to industry in 2022, Dr. Grosch brought his extensive expertise in allergy diagnostics to Siemens Healthineers. Here, he continues to make significant contributions, supporting multiple functions with his specialized knowledge and advancing the field of allergy diagnostics.